EP Plenary session - Oral question - Working conditions of teachers in the EU

EP Plenary session - Commission statement - State of the EU solar industry in the light of unfair competition

EP Plenary session - Council and Commission statements - Fight against the resurgence of neo-fascism in Europe, also based on the parade that took place in Rome on 7 January

EP Plenary session - Council and Commission statements - Presentation of the programme of activities of the Belgian Presidency

EP Plenary session - Need for EU, international to attacks in Red Sea, continued support to Yemeni peace process

EP Plenary - Council and Commission statements - Outcome of the UN Climate Change Conference 2023 in Dubai, United Arab Emirates (COP28)

EP Plenary session - Council and Commission statements - European Defence investment programme (EDIP)

EP Plenary session - Topical debate (Rule 162) - EU strategy to assist young people facing the housing and cost of living crisis

EP Plenary session - Statement by the Vice-President of the Commission/High Representative of the Union for Foreign Affairs and Security Policy - Need to release all hostages, to achieve a humanitarian ceasefire and prospect of the two-state solution

EP Plenary session - Role of tax policy in times of crisis

EP Conference of Presidents meets the upcoming Belgian Presidency - Family Photo with the Belgian Federal Parliament

EP Conference of Presidents meets the upcoming Belgian Presidency - Meeting with the Belgian Government

EP Conference of Presidents meets the upcoming Belgian Presidency - Family Photo with the Belgian Government

EP Plenary session - Proposal of the European Parliament for the amendment of Treaties

EP Plenary session - Framework of measures for strengthening Europe’s netzero technology products manufacturing ecosystem (Net Zero Industry Act)

EP Plenary session - Commission statements - State of the Energy Union

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on research and innovation. Opening statements by the rapporteurs Marc BOTENGA - Establishing Horizon Europe – laying down its rules for participation and dissemination; Christian EHLER (EPP, DE) - Specific Programme implementing Horizon Europe – the Framework Programme for Research and Innovation; Marisa MATIAS (The Left, PT) - European Institute of Innovation and Technology; Maria da Graça CARVALHO (EPP, PT) - Strategic Innovation Agenda of the European Institute of Innovation and Technology; and by Mariya GABRIEL, European Commissioner for Innovation, Research, Culture, Education and Youth. This transcription speech is the result of an automatic process. Check against delivery.

Joint debate on research and innovation: opening statements by the rapporteurs and by Mariya GABRIEL, European Commissioner for Innovation, Research, Culture, Education and Youth

During the plenary session (24-25 March 2021) in the European Parliament in Brussels, MEPs debate on a new EU-Africa Strategy - a partnership for sustainable and inclusive development.

A new EU-Africa Strategy - a partnership for sustainable and inclusive development: MEPs debate

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs debate on the programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

During the plenary session, MEPs debate and cast their final vote on the €5.1 billion EU4Health programme for 2021-2027. The programme aims to make EU health systems more resilient, address cross-border health threats and make medicines and medical devices more available, accessible and affordable. Statements by Stella KYRIAKIDES, European Commissioner for Health and Food Safety, Jytte GUTELAND (S&D, SE), Luisa REGIMENTI (ID, IT), Joanna Maria KOPCIŃSKA (ECR, PL), Frédérique RIES (Renew, BE), Marc BOTENGA (The Left, BE) and Cristian-Silviu BUŞOI (EPP, RO), Rapporteur.

EU4Health Programme: extracts from the debate and the vote and statement by Cristian-Silviu BUŞOI (EPP, RO)

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Q&A with CEOs of the pharmaceutical industry Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur ,Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry

During the plenary session of the European Parliament in Brussels (08-11 February 2021), MEPs debate the state of play of the EU's COVID-19 Vaccination Strategy.

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 1)

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations. MEPs debate 1/3

EU global strategy on COVID-19 vaccinations: MEPs debate 1/3

During the plenary session of the European Parliament in Brussels (14-18 December 2020), MEPs debate future relations between the European Union and the United Kingdom. MEPs debate (part 2)

Future relations between the EU and the UK: MEPs debate (part 2)

During the plenary session (14-18 December 2020), mainly in Brussels, MEPs debate an EU strategy for COVID-19 vaccinations that addresses challenges inside and outside the EU. MEPs debate

Preparation of an EU Strategy on COVID-19 vaccination, including its external dimension: MEPs debate

During the remote plenary session (23-26/11/2020) of the European Parliament in Brussels, MEPs debate on a pharmaceutical strategy for Europe in the framework of the Covid-19 outbreak with Stella KYRIAKIDES, European Commissioner for Health and Food Safety. MEPs statements by Dolors MONTSERRAT (EPP, ES), Heléne FRITZON (S&D, SE), Kim VAN SPARRENTAK (Greens/EFA, NL), Frédérique RIES (RE, BE), Marc BOTENGA (GUE/NGL, BE).

Pharmaceutical strategy for Europe: extracts from the debate

During the plenary session of the European Parliament in Brussels (19-23 October 2020), MEPs debate. EU measures to mitigate social and economic impact of Covid-19. MEPs debate

Plenary session: EU measures to mitigate social and economic impact of Covid-19. MEPs debate

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 1 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 1/2 Q&A with ENVI and ITRE Members.

During the plenary session of the European Parliament in Brussels (23 July 2020), debate on the conclusions of the extraordinary European Council meeting (17-21 July). MEPs debate (part 2)

Conclusions of the extraordinary European Council meeting (17-21 July): MEPs debate (part 2)

During the plenary session in the European Parliament in Brussels (13-16 May 2020), debate on vaccines and therapeutics in the context of Covid-19. First round political group leaders

Vaccines and therapeutics in the context of Covid-19: First round political group leaders

During the plenary session in the European Parliament in Brussels (13-16 May 2020), debate on the Conclusions of the extraordinary European Council meeting of 23 April 2020 and New MFF, own resources and Recovery plan. MEPs debate (part 1)

Conclusions of the extraordinary European Council meeting of 23 April 2020 and New MFF, own resources and Recovery plan: MEPs debate (part 1)

During the plenary session in the European Parliament in Brussels (13-16 May 2020), MEPs debate on the Conclusions of the extraordinary European Council meeting of 23 April 2020 and New MFF, own resources and Recovery plan. MEPs debate (part 2) Overlap with part 1

Conclusions of the extraordinary European Council meeting of 23 April 2020 and New MFF, own resources and Recovery plan: MEPs debate (part 2)

During the plenary session to coordinate the EU’s action to combat the COVID-19 pandemic and its consequences in the European Parliament in Brussels (16 April 2020), MEPs debate (part 1)

EU coordinated action to combat the COVID-19 pandemic and its consequences: MEPs debate (part 1)

During the extraordinary plenary session to coordinate the EU’s response to the COVID-19 outbreak in the European Parliament in Brussels (26 March 2020), MEPs debate on the topic.

75 resultat